Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares OutstandingShares OutstandingShares Repurchased
Ratios

Actinium Pharmaceuticals (ATNM) Shares Issued (2021 - 2024)

Actinium Pharmaceuticals (ATNM) has disclosed Shares Issued for 4 consecutive years, with $5.2 million as the latest value for Q3 2024.

  • Quarterly Shares Issued rose 83.43% to $5.2 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $31.1 million through Sep 2024, up 69.79% year-over-year, with the annual reading at $29.3 million for FY2024, 100.21% up from the prior year.
  • Shares Issued for Q3 2024 was $5.2 million at Actinium Pharmaceuticals, down from $24.6 million in the prior quarter.
  • The five-year high for Shares Issued was $24.6 million in Q2 2024, with the low at $6000.0 in Q2 2021.
  • Average Shares Issued over 4 years is $5.5 million, with a median of $2.9 million recorded in 2023.
  • Peak annual rise in Shares Issued hit 151.09% in 2024, while the deepest fall reached 90.26% in 2024.
  • Over 4 years, Shares Issued stood at $6000.0 in 2021, then skyrocketed by 81466.67% to $4.9 million in 2022, then plummeted by 75.62% to $1.2 million in 2023, then surged by 339.9% to $5.2 million in 2024.
  • According to Business Quant data, Shares Issued over the past three periods came in at $5.2 million, $24.6 million, and $75000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.